Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

Nonmedical and medical ketamine use with Owen Bowden-Jones and Arun Sahai

In this episode, Dr Elle Wadsworth speaks to Professor Owen Bowden-Jones from Central North-West London NHS Foundation and Mr Arun Sahai from Guy’s and St Thomas’ Hospitals NHS Trust, both in the UK. The interview covers an editorial they wrote with Professor Paul Dargan on responses to non-medical and medical ketamine use, including concerns about the increasing harms from illicit ketamine and excitement about the potential therapeutic value of ketamine.

We apologise for the sound quality at points during this episode, but we promise its worth the listen!

· Ketamine and its uses [01:15]

· Why ketamine is listed as an essential medicine by the World Health Organisation [01:59]

· The differing uses of ketamine: an essential medicine, a novel therapeutic drug, and a recreational drug [3:00]

· Ketamine’s damage to the urinary tract and the liver [04:30]

· Available treatments for the physical harms of ketamine [07:45]

· Whether substance use treatment services in the UK are fit-for-purpose when it comes to ketamine [11:06]

· Some of the reasons why is ketamine a popular drug now [15:38]

· The potential therapeutic value of ketamine for many disorders [17:29]

· The importance of communicating information to people who use ketamine [19:19]

About Arun Sahai: Mr Arun Sahai, PhD, FRCS (Urol), BSc (Hons.), is a Consultant Urological Surgeon in Functional urology (bladder dysfunction, incontinence, uro-neurology and urinary tract reconstruction) at Guy’s and St Thomas’ Hospitals NHS Trust and an Honorary Reader within King’s College London. He is the current chair of the section of functional and reconstructive urology at the British Association of Urological Surgeons (BAUS). He is the lead for undergraduate education in surgery for King's College London. His research interests include various aspects of benign bladder dysfunction and prostate cancer survivorship. He is active in both commercial and non-commercial clinical trials and has published more than 100 peer reviewed international papers and more than 15 book chapters.

About Owen Bowden-Jones: Professor Owen Bowden-Jones CBE is a Consultant in Addiction Psychiatry at the CNWL Club Drug Clinic, London and an Honorary Professor at University College London. In 2010, Owen founded the CNWL Club Drug Clinic, an innovative service offering treatment for emerging drug problems, including novel psychoactive substances and club drugs. National roles include President of the Society for the Study of Addiction, Chair of the Advisory Council on the Misuse of Drugs, Policy Fellow at the University of Cambridge, trustee at the charity Student Minds and Registrar at the Royal College of Psychiatrists. Owen is the past-Chair of the Faculty of Addictions at the Royal College of Psychiatrists and was previously a national clinical adviser to Public Health England.

Original editorial: Responding to medicinal and non-medicinal ketamine use https://doi.org/10.1111/add.70075

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal. The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Avsnitt(105)

The Paper Authoring Tool (PAT) with Robert West

The Paper Authoring Tool (PAT) with Robert West

Rob Calder talks to Professor Robert West about the Paper Authoring Tool (PAT). Professor West talks about how PAT can be used in the design and write-up phases of a randomised controlled trials, about how it saves time for reviewers and journals and about how using the PAT can make your research more rigorous, well reported and discoverable. He also discusses the future of research publishing and how computer reading can save months or years on evidence synthesis and how this relates to the Human Behaviour Change Project. There is also a small section on the interaction between computers, humans and chess.West, R. PAT: an on‐line paper authoring tool for writing up randomized controlled trials. Addiction 2021; 116: 1938-1940paperauthoringtool.com Hosted on Acast. See acast.com/privacy for more information.

14 Sep 202127min

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Cannabis, opioids and the gateway hypothesis with Jack Wilson

Jack Wilson talks to Rob Calder about his recent systematic review and meta-analysis on whether cannabis use increases the likelihood of later life opioid use or opioid use disorders. Jack talks about the limitations of the literature, the influence that the gateway hypothesis has had on policy and on some of the different types of studies that explore this issue. Wilson J, Mills K, Freeman TP, Sunderland M, Visontay R, and Marel C. Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction 2021; doi:10.1111/add.15581 https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15581 Hosted on Acast. See acast.com/privacy for more information.

15 Juli 202116min

Cannabis, schizophrenia and genetics with Emma Johnson

Cannabis, schizophrenia and genetics with Emma Johnson

Dr Emma Johnson talks to Rob Calder about shared genetic liabilities for cannabis use disorder and schizophrenia and the role of tobacco smoking. Dr Johnson talks about the implications of this research on the evidence for a causal relationship between cannabis and schizophrenia and for other genetic associations relating to substance use and psychiatric disorders. The episode also covers to ever-fascinating issue of mendelian randomisation. (Be sure to check out episode 22 too!)Johnson E.C., Hatoum A.S., Deak J.D., Polimanti R, Murray R.M., Edenberg H.J., et al. The relationship between cannabis and schizophrenia: a genetically informed perspective. Addiction 2021 https://doi.org/10.1111/add.15534 Hosted on Acast. See acast.com/privacy for more information.

14 Juni 202116min

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Pay for Performance funding and emergency hospital admissions with Thomas Mason

Rob Calder talks to Dr Thomas Mason about his research on pay for performance models of addiction treatment and how they were associated with increased emergency hospital admissions. Mason T, Whittaker W, Jones A, Sutton M. Did paying drugs misuse treatment providers for outcomes lead to unintended consequences for hospital admissions? Difference-in-differences analysis of a pay-for-performance scheme in England. Addiction 2021 https://doi.org/10.1111/add.15486 Hosted on Acast. See acast.com/privacy for more information.

1 Juni 202119min

Vaping and smoking cessation with Máirtín McDermott and Leonie Brose

Vaping and smoking cessation with Máirtín McDermott and Leonie Brose

Rob Calder talks to Dr Máirtín McDermott and Dr Leonie Brose about their research into the effectiveness of e-cigarettes for quitting smoking.McDermott M.S, East K.A, Brose L.S, McNeill A, Hitchman S.C, Partos T.R. The effectiveness of using e‐cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom. Addiction 2021. https://doi.org/10.1111/add.15474 Hosted on Acast. See acast.com/privacy for more information.

28 Apr 202117min

Alcohol attributable mortality in the Americas with Maristela Monteiro

Alcohol attributable mortality in the Americas with Maristela Monteiro

Rob Calder talks to Dr Maristela Monteiro about deaths in the Americas between 2013 and 2015 that were 100% attributable to alcohol. Chrystoja B.R, Monteiro M.G, Owe G, Pinheiro Gawryszewski V, Rehm J, Shield K. Mortality in the Americas from 2013 to 2015 resulting from diseases, conditions and injuries which are 100% alcohol attributable. Addiction 2021 https://doi.org/10.1111/add.15475 Hosted on Acast. See acast.com/privacy for more information.

12 Apr 202120min

Social norms and smoking behaviour with Katie East

Social norms and smoking behaviour with Katie East

Rob Calder speaks to Dr Katie East about her research into social norms in relation to smoking behaviourEast K, McNeill A, Thrasher JF, Hitchman SC. Social norms as a predictor of smoking uptake among youth: a systematic review, meta‐analysis and meta‐regression of prospective cohort studies. Addiction 2021 https://doi.org/10.1111/add.15427 Hosted on Acast. See acast.com/privacy for more information.

8 Apr 202111min

Heroin use and general population surveys with Jon Caulkins

Heroin use and general population surveys with Jon Caulkins

Rob Calder speaks to Professor Jon Caulkins about his Addiction Opinion & Debate article discussing the difficulties of measuring heroin use with general population surveysReuter P, Caulkins JP, Midgette G. Heroin Use Cannot Be Measured Adequately with a General Population Survey. Addiction 2021 https://doi.org/10.1111/add.15458 Hosted on Acast. See acast.com/privacy for more information.

30 Mars 202116min

Populärt inom Vetenskap

p3-dystopia
paranormalt-med-caroline-giertz
dumma-manniskor
svd-nyhetsartiklar
allt-du-velat-veta
rss-vetenskapligt-talat
kapitalet-en-podd-om-ekonomi
rss-vetenskapspodden
medicinvetarna
rss-ufobortom-rimligt-tvivel
dumforklarat
sexet
det-morka-psyket
bildningspodden
rss-vetenskapsradion-2
rss-vetenskapsradion
halsorevolutionen
rss-i-hjarnan-pa-louise-epstein
rss-spraket
a-kursen